(Total Views: 524)
Posted On: 01/05/2022 2:21:03 PM
Post# of 156572
Yup we still need to do another trail which would be bigger. This is why a partnership for NASH seems like the best bet.
As for BTD we still have time to hear about it. I thought the bar was pretty low for BTD and are results looked pretty good compared to the competition. I know it was a small sample size but idk figured BTD was a given. Guess we will have to wait.
As for BTD we still have time to hear about it. I thought the bar was pretty low for BTD and are results looked pretty good compared to the competition. I know it was a small sample size but idk figured BTD was a given. Guess we will have to wait.
(1)
(0)
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Watchman Oversight Program
https://investorshangout.com/images/MYImages/...G_2859.png
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Watchman Oversight Program
https://investorshangout.com/images/MYImages/...G_2859.png
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
